Treatment of Bile Acid Malabsorption With Liraglutide

NCT03955575 · Completed

Last updated 2026-05-28

This clinical trial is testing whether the medication liraglutide can help reduce the number of bowel movements in people with bile acid malabsorption.

Status Completed The study has finished.

Phase Phase 4 Monitors a drug already on the market.

Type Interventional (clinical trial)

Design Randomized, triple-blind basic-science study

Participants 52 people

Who can join Ages 18–75 · all sexes

Timeline Started 2019-03 · est. completion 2022-05

Where 1 site · Denmark

What this study is testing ClinicalTrials.gov NCT03955575 ↗

Description as written by the study sponsor.

Comparing the effect of Liraglutide on bile acid malabsorption, with colesevelam

Treatments tested

Liraglutide 6 MG/ML Drug

Liraglutide as injections.
Colesevelam Drug

3 x 625 miligram 2 times a day.

Main thing measured	Change in stool fequency
Sponsor	Filip Krag Knop
Conditions studied	Bile Acid Malabsorption
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT03955575 ↗